comparemela.com

Latest Breaking News On - Linda llewelyn - Page 1 : comparemela.com

Health Catalyst, Inc. (NASDAQ:HCAT) Insider Sells $12,250.55 in Stock

Health Catalyst, Inc. (NASDAQ:HCAT) Insider Sells $12,250.55 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Los-angeles
California
United-states
Piper-sandler
Linda-llewelyn
Health-catalyst-price-performance
Nepsis-inc
News-ratings-for-health-catalyst-daily
Hedge-funds-weigh-in-on-health-catalyst
Los-angeles-capital-management
Capital-partners
Nasdaq

Health Catalyst's (HCAT) Overweight Rating Reaffirmed at Cantor Fitzgerald

Health Catalyst (NASDAQ:HCAT – Get Free Report)‘s stock had its “overweight” rating reaffirmed by Cantor Fitzgerald in a report issued on Wednesday, Benzinga reports. They currently have a $16.00 price objective on the stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 156.41% from the stock’s previous close. Other research analysts have also […]

United-states
Linda-llewelyn
Jpmorgan-chase-co
Analyst-recommendations-for-health-catalyst
Insider-activity-at-health-catalyst
Keycorp
Vanguard-group-inc
Securities-exchange-commission
Canaccord-genuity-group
Health-catalyst-company-profile
Hedge-funds-weigh-in-on-health-catalyst
Health-catalyst-price-performance

Health Catalyst (NASDAQ:HCAT) Stock Rating Reaffirmed by Cantor Fitzgerald

Cantor Fitzgerald reaffirmed their overweight rating on shares of Health Catalyst (NASDAQ:HCAT – Free Report) in a research report sent to investors on Tuesday, Benzinga reports. They currently have a $16.00 price target on the stock. A number of other equities analysts also recently commented on the stock. Barclays initiated coverage on shares of Health […]

United-states
Linda-llewelyn
Analyst-recommendations-for-health-catalyst
Canaccord-genuity-group
Jpmorgan-chase-co
News-ratings-for-health-catalyst-daily
Health-catalyst-inc
Insider-transactions-at-health-catalyst
Cantor-fitzgerald
Jefferies-financial-group-inc
Barclays-plc
Hedge-funds-weigh-in-on-health-catalyst

KeyCorp Cuts Health Catalyst (NASDAQ:HCAT) Price Target to $10.00

Health Catalyst (NASDAQ:HCAT – Free Report) had its target price lowered by KeyCorp from $12.00 to $10.00 in a research report released on Monday morning, Benzinga reports. The firm currently has an overweight rating on the stock. A number of other research firms have also weighed in on HCAT. Guggenheim upgraded shares of Health Catalyst […]

United-states
Linda-llewelyn
Canaccord-genuity-group
Keycorp
Nasdaq
News-ratings-for-health-catalyst-daily
Pricet-rowe-associates-inc
Hedge-funds-weigh-in-on-health-catalyst
Vident-advisory
Capital-partners
Health-catalyst-inc
Nuveen-asset-management

Canaccord Genuity Group Trims Health Catalyst (NASDAQ:HCAT) Target Price to $11.00

Health Catalyst (NASDAQ:HCAT – Free Report) had its target price lowered by Canaccord Genuity Group from $12.00 to $11.00 in a report issued on Friday morning, Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. Several other brokerages have also weighed in on HCAT. Stifel Nicolaus dropped their price objective on […]

United-states
Canada
Piper-sandler
Stifel-nicolaus
Linda-llewelyn
Impax-asset-management-group
Vanguard-group-inc
Analyst-recommendations-for-health-catalyst
Canaccord-genuity-group
Health-catalyst-inc
Health-catalyst
Royal-bank

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.